Blaine Davis | CFO |
Carsten Brunn | CEO, President & Director |
Peter Traber | Chief Medical Officer |
Joseph Schwartz | SVB Securities |
Kristen Kluska | Cantor Fitzgerald |
John Newman | Canaccord Genuity |
Dipesh Patel | H.C. Wainwright & Co. |
Uy Ear | Mizuho Securities |
Gil Blum | Needham & Company |
Good morning, and thank you for joining the Selecta Biosciences First Quarter 2023 Earnings Call. [Operator Instructions]. I would now like to turn the call over to Blaine Davis, Chief Financial Officer at Selecta. Please go ahead.
Thank you, and good morning, everyone.